产品标题 产品货号 产品规格 厂家
Human Breast; Fibrocystic breast disease from ORIGENE TECHNOLOGIESCS5470155x5umORIGENE TECHNOLOGIES
Human Breast; Fibrocystic breast disease from ORIGENE TECHNOLOGIESCS6158225x5umORIGENE TECHNOLOGIES
Human Breast; Fibrocystic breast disease from ORIGENE TECHNOLOGIESCS6158245x5umORIGENE TECHNOLOGIES
Human Breast; Fibrocystic breast disease from ORIGENE TECHNOLOGIESCS6158235x5umORIGENE TECHNOLOGIES
Human Breast; Fibrocystic breast disease from ORIGENE TECHNOLOGIESCS6165495x5umORIGENE TECHNOLOGIES
Human Breast; Fibrocystic breast disease from ORIGENE TECHNOLOGIESCS6180155x5umORIGENE TECHNOLOGIES
Human Breast; Fibrocystic breast disease from ORIGENE TECHNOLOGIESCS6216245x5umORIGENE TECHNOLOGIES
Human Breast; Fibrocystic breast disease from ORIGENE TECHNOLOGIESCS6232375x5umORIGENE TECHNOLOGIES
Human Breast; Fibrocystic breast disease from ORIGENE TECHNOLOGIESCS5579725x5umORIGENE TECHNOLOGIES
Human Breast; Fibrocystic breast disease from ORIGENE TECHNOLOGIESCS6409945x5umORIGENE TECHNOLOGIES
Human Breast; Fibrocystic breast disease from ORIGENE TECHNOLOGIESCS6232365x5umORIGENE TECHNOLOGIES
Human Breast; Fibrocystic breast disease from ORIGENE TECHNOLOGIESCS6444635x5umORIGENE TECHNOLOGIES
Human Breast; Fibrocystic changes of breast, atypical from ORIGENE TECHNOLOGIESCS8136045x5umORIGENE TECHNOLOGIES
Human Breast; Fibrocystic changes of breast, atypical from ORIGENE TECHNOLOGIESCS8133925x5umORIGENE TECHNOLOGIES
Human Breast; Fibrocystic changes of breast, atypical from ORIGENE TECHNOLOGIESCS5341145x5umORIGENE TECHNOLOGIES
Human Breast; Fibrocystic changes of breast, atypical from ORIGENE TECHNOLOGIESCS6487225x5umORIGENE TECHNOLOGIES
Human Breast; Fibrocystic breast disease from ORIGENE TECHNOLOGIESCS6444625x5umORIGENE TECHNOLOGIES
Human Breast; Fibrocystic changes to breast from ORIGENE TECHNOLOGIESCS7007455x5umORIGENE TECHNOLOGIES
Human Breast; Fibrocystic changes of breast, atypical from ORIGENE TECHNOLOGIESCS6487165x5umORIGENE TECHNOLOGIES
Human Breast; Fibrocystic changes to breast from ORIGENE TECHNOLOGIESCS7047085x5umORIGENE TECHNOLOGIES
Human Breast; Fibrocystic changes to breast from ORIGENE TECHNOLOGIESCS7044545x5umORIGENE TECHNOLOGIES
Human Breast; Fibrocystic changes to breast from ORIGENE TECHNOLOGIESCS7029355x5umORIGENE TECHNOLOGIES
Human Breast; Fibrocystic changes to breast from ORIGENE TECHNOLOGIESCS7048445x5umORIGENE TECHNOLOGIES
Human Breast; Fibrocystic changes to breast from ORIGENE TECHNOLOGIESCS7047695x5umORIGENE TECHNOLOGIES
Human Breast; Fibrocystic changes to breast from ORIGENE TECHNOLOGIESCS7049205x5umORIGENE TECHNOLOGIES
Human Breast; Fibrocystic changes to breast from ORIGENE TECHNOLOGIESCS7061695x5umORIGENE TECHNOLOGIES
Human Breast; Fibrocystic changes to breast from ORIGENE TECHNOLOGIESCS7063575x5umORIGENE TECHNOLOGIES
Human Breast; Fibrocystic changes to breast from ORIGENE TECHNOLOGIESCS7061705x5umORIGENE TECHNOLOGIES
Human Breast; Fibrocystic changes to breast from ORIGENE TECHNOLOGIESCS7066695x5umORIGENE TECHNOLOGIES
Human Breast; Fibrocystic changes to breast from ORIGENE TECHNOLOGIESCS7086325x5umORIGENE TECHNOLOGIES
Human Breast; Fibrocystic changes to breast from ORIGENE TECHNOLOGIESCS7087965x5umORIGENE TECHNOLOGIES
Human Breast; Fibrocystic changes to breast from ORIGENE TECHNOLOGIESCS7088695x5umORIGENE TECHNOLOGIES
Human Breast; Fibrocystic changes to breast from ORIGENE TECHNOLOGIESCS7088705x5umORIGENE TECHNOLOGIES
Human Breast; Fibrocystic changes to breast from ORIGENE TECHNOLOGIESCS7089655x5umORIGENE TECHNOLOGIES
Human Breast; Fibrocystic changes to breast from ORIGENE TECHNOLOGIESCS7093115x5umORIGENE TECHNOLOGIES
Human Breast; Fibrocystic changes to breast from ORIGENE TECHNOLOGIESCS7093105x5umORIGENE TECHNOLOGIES
Human Breast; Fibrocystic changes to breast from ORIGENE TECHNOLOGIESCS7096225x5umORIGENE TECHNOLOGIES
Human Breast; Fibrocystic changes to breast from ORIGENE TECHNOLOGIESCS7105925x5umORIGENE TECHNOLOGIES
Human Breast; Fibrocystic changes to breast from ORIGENE TECHNOLOGIESCS7105915x5umORIGENE TECHNOLOGIES
Human Breast; Fibrocystic changes to breast from ORIGENE TECHNOLOGIESCS7109085x5umORIGENE TECHNOLOGIES
Human Breast; Fibrocystic changes to breast from ORIGENE TECHNOLOGIESCS7105955x5umORIGENE TECHNOLOGIES
Dapl1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5042771 kitORIGENE TECHNOLOGIES
Human Breast; Fibrocystic changes to breast from ORIGENE TECHNOLOGIESCS7124355x5umORIGENE TECHNOLOGIES
Human Breast; Fibrocystic changes to breast from ORIGENE TECHNOLOGIESCS7126665x5umORIGENE TECHNOLOGIES
DAP Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30112010 ugORIGENE TECHNOLOGIES
Dapper, antagonist of beta-catenin, homolog 2 (Xenopus laevis) (DACT2) from ORIGENE TECHNOLOGIESLY403742100 ugORIGENE TECHNOLOGIES
Dapper, antagonist of beta-catenin, homolog 3 (Xenopus laevis) (DACT3) from ORIGENE TECHNOLOGIESLY403420100 ugORIGENE TECHNOLOGIES
DAP3 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH32318210 ugORIGENE TECHNOLOGIES
DAPP1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4154741 kitORIGENE TECHNOLOGIES
DARC - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4046801 kitORIGENE TECHNOLOGIES
 |< < 4276 4277 4278 4279 4280 4281 4282 4283 4284 > >| 第 4279/6274 页